top of page

A2A NEWS

Search

A2A Panelist

  • Writer: A2A Pharma
    A2A Pharma
  • May 16, 2019

Updated: Feb 7, 2020

A2A Founder & CEO Edward Painter was a panelist at BIO Investor forum panel entitled "Applying artificial intelligence to improve therapy development today"


Fierce Biotech

  • Writer: A2A Pharma
    A2A Pharma
  • May 16, 2019

Updated: Feb 7, 2020

Insilico and A2A launched new Deuchenne-focused AI drug company


bottom of page